EMD expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.525600E-01
Normal-vs-Stage2
8.959800E-01
Normal-vs-Stage3
4.590800E-01
Normal-vs-Stage4
8.041000E-01
Stage1-vs-Stage2
6.831200E-01
Stage1-vs-Stage3
3.332200E-01
Stage1-vs-Stage4
8.995400E-01
Stage2-vs-Stage3
2.318400E-01
Stage2-vs-Stage4
8.793400E-01
Stage3-vs-Stage4
3.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.802200E-01
Normal-vs-AfricanAmerican
9.024800E-01
Normal-vs-Asian
7.712000E-01
Caucasian-vs-AfricanAmerican
7.486400E-01
Caucasian-vs-Asian
8.210000E-01
AfricanAmerican-vs-Asian
6.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.056800E-01
Normal-vs-Female
8.904600E-01
Male-vs-Female
8.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.828200E-01
Normal-vs-Age(41-60Yrs)
6.212800E-01
Normal-vs-Age(61-80Yrs)
9.138400E-01
Normal-vs-Age(81-100Yrs)
7.393600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.083200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.314780E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.633000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.076100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.533600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.687200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.736200E-01
Normal-vs-Daily Drinker
8.608600E-01
Normal-vs-Weekly Drinker
4.917200E-01
Normal-vs-Occasional Drinker
9.215200E-01
Normal-vs-Social Drinker
8.867400E-01
Non Drinker-vs-Daily Drinker
7.811600E-01
Non Drinker-vs-Weekly Drinker
1.712430E-01
Non Drinker-vs-Occasional Drinker
8.929400E-01
Non Drinker-vs-Social Drinker
7.894600E-01
Daily Drinker-vs-Weekly Drinker
2.168400E-01
Daily Drinker-vs-Occasional Drinker
9.088000E-01
Daily Drinker-vs-Social Drinker
9.562600E-01
Weekly Drinker-vs-Occasional Drinker
2.081400E-01
Weekly Drinker-vs-Social Drinker
2.786600E-01
Occasional Drinker-vs-Social Drinker
8.935400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.879200E-01
Normal-vs-Grade 2
7.096000E-01
Normal-vs-Grade 3
7.042400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.540000E-01
Grade 1-vs-Grade 3
5.702800E-01
Grade 1-vs-Grade 4
6.879200E-01
Grade 2-vs-Grade 3
7.844200E-01
Grade 2-vs-Grade 4
7.096000E-01
Grade 3-vs-Grade 4
7.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.016000E-01
Normal-vs-NonDiabetic
7.414800E-01
Diabetic-vs-NonDiabetic
1.592410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.035700E-02
Normal-vs-NoPancreatitis
9.359600E-01
Pancreatitis-vs-NoPancreatitis
2.357800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.582000E-01
Normal-vs-N1
9.849200E-01
N0-vs-N1
2.647400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.752600E-01
Normal-vs-TP53-NonMutant
7.358600E-01
TP53-Mutant-vs-TP53-NonMutant
3.925700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
